Mumbai, April 9 -- Zim Laboratories (ZIM)has entered into a Dossier License, Product Supply, and Technology Know-How License Agreement with Globalpharma Co. (L.L.C.), a leading UAE-based pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments, one of the region's premier investment entities.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.